Buy Regeneron Pharmaceuticals Shares

Regeneron Pharmaceuticals Logo

How COVID-19 has impacted Regeneron Pharmaceuticals and measures they’ve taken as a business to combat it. Read on below.

Regeneron Pharmaceuticals Shares

Our aim is to help you buy Regeneron Pharmaceuticals shares armed with as much research and information as possible.

Below we’ve aggregated up to date information on Regeneron Pharmaceuticals including a detailed coronavirus section, full company information and live share prices and trend graphs. We’ve also added a step by step guide showing you exactly how to buy Regeneron shares.

About Regeneron Pharmaceuticals

Regneron Pharmaceuticals develops and markets drug products, with seven approved by the Federal Drug Administration (FDA) and several still in the viable pipeline.

These treatments span the gamut of inflammatory diseases (like rheumatoid arthritis), cancer, infectious diseases, pain treatment and some rare diseases. Their research incorporates a genetic center that focuses on genetic research. It currently employs approximately 8,000 workers.

In 2015 Regneron announced a collaboration with Sanofi, a French multi-national pharmaceutical company. Their joint goal was to work on immuno-oncology drugs. In May 2020 Regeneron repurchased approximately $5 billion worth of Regeneron shares held by Sanofi.

The company was established in 1988 by Leonard Schleifer and George Yancopoulos. It remains headquartered in Eastview, New York. Since 1991 it has been traded on the NASDAQ exchange as REGN.

How Coronavirus has impacted Regeneron Pharmaceuticals' share price

With the onset of Coronavirus, Regeneron announced that it was donating all of its time plus the necessary supplies and materials toward the production of a viral transport medium (VTM). This substance is used to preserve the samples sent for testing. This is estimated as a $1 million in-kind donation. The company also reported that it is retrofitting its facilities to enable to production of an antibody treatment for the disease. In addition, Regeneron has secured governmental funding for the costs of COVID-19 treatment development and manufacture. In addition, the company continues to work on other drug regimens in process.

March 30th

With Sanofi the first non-U.S. patient was treated with Kevzara® (sarilumab) for COVID-19 symptoms as part of a double-blind program.

May 26th

The FDA approved Dupixent® (dupilumab) for use in children from 6 to 11 who have moderate to severe diagnoses of atopic dermatitis which was not controlled by other topical medications.

May 29th

Release of the results from the Phase 2 trial of Libtayo® (cemiplimab-rwlc) shows longer durability and higher complete response in treatment of cutaneous squamous cell carcinoma (CSCC).

June 1st

The existing collaboration of Regeneron and Intella Therapeutics has been expanded to include the development of products for in vivo CRISPR/Cas9 in the treatment of hemophilia A and B. Regeneron also has non-exclusive rights to work independently in the development of ex vivo gene-edited products.

How to buy Regeneron Pharmaceuticals shares

It’s a very simple and straightforward process to getting started and owning a share of Regeneron Pharmaceuticals. Our step by step guide below will show you just how easy.

1. Pick a share trading platform.
We’ve provided a selection below to help you choose (many come with an app that you can manage from your phone).

2. Open an account with your chosen trading platform.
As with any account you’l be required to identify yourself with some personal details to make sure you are who you say you are.

3. Add a payment method.
You’ll be securely transferring money to your share trading platform in order to buy the shares, so you’ll need to add a way to pay.

4. Search for the company you want to buy shares in.
Each share trading platform has a simple way to locate the company you’ve identified.

5. Buy the shares.
Make sure you check the share price of the company you’re investing in and how much you’re investing (and ensure you’re happy with both) before you click the ‘buy’ button.

And that’s it, you’re now a shareholder. Congratulations!

Always remember that the value of your investments can go down as well as up. There’s a chance you may end up with less than you begin with. Capital is at risk.

Compare Brokers

We’ve compared the top trading platforms side by side, so you don’t have to. Choose the platform that suits your needs best.

Award winning, advanced trading platform.

ASSETS

Stocks, Options, ETFs, Futures

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0 + $1 per contract     OR

$2.50 per contract

ANNUAL FEE

0%

GO TO BROKER

Ally Invest

Very low fees plus a cash bonus offering.

ASSETS

Stocks, Options, Bonds, ETFs, Forex, Mutual funds

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0 + $0.50 per contract 

ANNUAL FEE

0%

GO TO BROKER

Robinhood

No commission, forex fees or account minimums.

ASSETS

Stocks, Options, ETFs, Cryptocurrencies

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0

ANNUAL FEE

0%

GO TO BROKER

Affiliate Disclaimer: Confideal may make a small amount of money through affiliate marketing when you sign up to any of the brokers listed on our website.

Confideal.io is an independent marketing website which only acts as an introducer to companies that offer share trading capabilities. Confideal.io is not authorised to give any advice and we are not liable for any financial advice provided by, or obtained through a third party. The information published on the Confideal.io website is for information purposes only. Confideal does not offer financial advice.

Copyright Confideal 2020. All rights reserved.